NCT02063594 - Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

NCTX (PEGylated Liposomal Iodixanol Injection)

Single dose of NCTX (PEGylated Liposomal Iodixanol Injection) administered at escalating doses from 9 mg I/kg up to 110 mg I/kg

DRUG

Saline Placebo

Single dose of 0.9% Sodium Chloride Injection, USP administered similarly and at an equivalent dose volume as the active drug

Trial Locations (1)

Quintiles Phase 1 Services, Overland Park